Summary
Latest filing:
Fred B. Davenport Jr. is Director of Medpace Holdings, Inc. (MEDP). 5 SEC Form 4 filings on record going back to 2025, most recently on 21 August 2026. Most recent open-market trade: sold $4.41M of MEDP on 21 August 2026. Lifetime open-market sales: $8.41M.
Recent transactions
8The latest 8 SEC Form 4 transactions reported by Fred B. Davenport Jr..
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Fred B. Davenport Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- August J. Troendle - $328.13M in MEDP purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Susan E. Burwig - $28.78M in MEDP purchases and sales in the last 12 months
- Stephen P. Ewald - $16.48M in MEDP purchases and sales in the last 12 months
- Robert O. Kraft - $6.21M in MEDP purchases and sales in the last 12 months
- Kevin M. Brady - $3.90M in MEDP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Fred B. Davenport Jr.?
Fred B. Davenport Jr. is a corporate insider, tracked as Director of Medpace Holdings, Inc. (MEDP). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Fred B. Davenport Jr. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Fred B. Davenport Jr. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($8.41M) across all tracked filings.
